Elkhorn S&P MidCap Energy Portfolio XE 深 沪
等待开盘 12-20 09:30:00 美东时间
9.7344
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 9.7344
- 总市值 0
- 52周最高 15.4786
- 市盈率 静 --
- 换手率 NaN.00%
- 52周最低 9.35
- 委 比 0.00%
- 总股本 --
- 历史最高 15.4786
- 量 比 0
- 振 幅 0.00%
- 历史最低 9.35
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Southern Cross Electrical Engineering Limited: Strategic Growth and Diversification
Southern Cross Electrical Engineering Limited ( ($AU:SXE) ) has shared an updat...
10-14 05:28
Confluent Surges Pre-Market On Reports It's Considering A Sale
Confluent shares soared after reports surfaced that the company is exploring a potential sale amid rising acquisition interest.
10-08 17:59
Tesla Showcases Optimus Bot At Disney's 'Tron: ARES' Premiere As Jared Leto Tries To 'Fight' A Robot
Tesla's Optimus humanoid robots make red carpet debut at Disney's Tron: ARES premiere featuring Jared Leto.
10-07 11:54
2030年新能源车渗透率或达70% 中外车企“双向奔赴”趋势正形成这场行业大会释放了这些信号！
“当前，全球新能源汽车市场稳健增长，汽车产业电动化、智能化、低碳化转型和基础设施建设协调有序推进。要以能源转型、数智变革、低碳发展为契机，持续扩大对外开放...
09-28 16:27
长安汽车朱华荣：预计2030年世界新能源车渗透率将提升至40%
专题：2025世界新能源汽车大会 “2025世界新能源汽车大会”于2025年9月27-29日在海口举办。主题为“产业变革与可持续发展”。中...
09-28 10:08
Circus Extends Partnership With Meta To Bring Llama AI Models Into Next-Gen Defense Robotics
Circus SE (XETRA: CA1), a global technology leader in AI robotics for autonomous nutrition systems and troop supply, today announces the extension of its collaborative partnership with Meta to its Llama for defense AI
09-24 19:19
XEBIO Finalizes Stock-Based Compensation for Directors
XEBIO Holdings CO., LTD. ( ($JP:8281) ) has provided an update. XEBIO Holdings ...
09-16 16:53
Palantir CEO Alex Karp Denies Spying On Americans, Says Firm Has 'Worst' Tech To Abuse Civil Liberties
Palantir CEO Alex Karp denied claims the company spies on Americans, stressing its software is built to protect civil liberties.
09-10 16:00
港股早知道 | 多家新势力交付量创新高：零跑汽车5.7万辆蝉联冠军；新世界发展澄清注资传言，尚未收到任何融资提议
多家新势力交付量创新高：零跑汽车5.7万辆蝉联冠军，蔚来突破3万辆；新世界发展澄清注资传言，尚未收到任何融资提议；天齐锂业年产50吨硫化锂中试项目落地>>
09-02 07:56
FDA Approves Novavax's Nuvaxovid For 2025–2026 Season As Only Protein-Based, Non-mRNA COVID-19 Vaccine In U.S.
Nuvaxovid™ is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination seasonGAITHERSBURG, Md., Aug. 27, 2025 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today
08-28 03:09
